Press release
Investigation announced for Investors in shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD)
An investigation for investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares over potential securities laws violations.
Investors who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by ACADIA Pharmaceuticals Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
San Diego, CA based ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders.
On Jul. 20, 2020, ACADIA Pharmaceuticals Inc. announced the U.S. FDA accepted for filing the sNDA. ACADIA Pharmaceuticals Inc. also reassured investors “[t]he FDA has also informed the company that it has not identified any potential review issues at this point in their evaluation and at this time they are not planning to hold an Advisory Committee meeting.”
On March 8, 2021, ACADIA Pharmaceuticals Inc. announced that on Mar. 3, 2021 the FDA informed the company that during review of the sNDA the agency identified deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time.
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) declined from $52.12 per share on February 22, 2021, to as low as $23.35 per share on March 9, 2021.
Those who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) here
News-ID: 2269208 • Views: …
More Releases from Shareholders Foundation
Investors in shares of iRhythm Technologies, Inc. (NASDAQ: IRTC) should contact …
An investigation was announced for current long-term investors in shares of iRhythm Technologies, Inc. (NASDAQ: IRTC) concerning potential breaches of fiduciary duties by certain directors and officers of iRhythm Technologies, Inc..
Investors who are current long term investors in iRhythm Technologies, Inc. (NASDAQ: IRTC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long…
Investors in Thoughtworks Holding, Inc. (NASDAQ: TWKS) should contact the Shareh …
An investigation was announced concerning whether the takeover of Thoughtworks Holding, Inc. is unfair to NASDAQ: TWKS stockholders.
Investors who purchased shares of Thoughtworks Holding, Inc. (NASDAQ: TWKS) and currently hold any of those NASDAQ: TWKS shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain officers and directors of Thoughtworks Holding, Inc. breached their…
Investigation announced for Investors who lost money with shares of Domino's Piz …
An investigation was announced for investors of Domino's Pizza, Inc. (NYSE: DPZ) shares over potential securities laws violations by Domino's Pizza, Inc.
Investors who purchased shares of Domino's Pizza, Inc. (NYSE: DPZ), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Domino's Pizza, Inc. (NYSE: DPZ)…
Investigation announced for Long-Term Investors in shares of Ocugen, Inc. (NASDA …
An investigation was announced over potential breaches of fiduciary duties by certain directors and officers of Ocugen, Inc.
Investors who are current long term investors in Ocugen, Inc. (NASDAQ: OCGN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: OCGN stocks follows a lawsuit filed against Ocugen, Inc. over alleged…
More Releases for ACAD
Investigation announced for Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: AC …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of ACADIA Pharmaceuticals Inc..
Investors who are current long term investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ACAD stocks follows a lawsuit filed against ACADIA…
Deadline on June 18th coming up in Lawsuit for Investors in ACADIA Pharmaceutica …
A deadline is coming up on June 18, 2021 in the lawsuit filed for certain investors of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) over alleged securities laws violations by ACADIA Pharmaceuticals Inc.
Investors who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) have certain options and there are strict and short deadlines running. Deadline: June 18, 2021. NASDAQ: ACAD stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
Lawsuit filed for Investors in shares of ACADIA Pharmaceuticals Inc. (NASDAQ: AC …
An investor, who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), filed a lawsuit over alleged violations of Federal Securities Laws by ACADIA Pharmaceuticals Inc.
Investors who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) have certain options and for certain investors are short and strict deadlines running. Deadline: June 18, 2021. NASDAQ: ACAD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
San Diego, CA based…
Business Etiquette Training Industry Market Detailed Insights on Upcoming Trends …
Business etiquette training, a key part of soft skills & communication, facilitated by MMM enlightens participants on the accepted behaviour patterns and manners key to their profession. It emphasis on a set of practices used and accepted in a multi-national work environment.
It is designed for organizations that wish to ensure their employees are aware of workplace expectations and office manners. The class covers topics such as cubicle etiquette, email etiquette,…
Milk Allergy Clinical Trials Review Market Outlook to 2023 – American College …
Oct 2018, New York USA (News)- Milk allergy is an adverse immune reaction to one or more proteins in cow's milk. When allergy symptoms occur, they can occur rapidly or have a gradual onset. The former may include anaphylaxis, a potentially life-threatening condition which requires treatment with epinephrine among other measures. The latter can take hours to days to appear, with symptoms including atopic dermatitis, inflammation of the esophagus, enteropathy…
John McEnroe Tennis Acad. Scholarship Tryout, Scouting Combine at SPORTIME Randa …
Young hopefuls from across the tri-state area will be out in force at SPORTIME Randall's Island, the John McEnroe Tennis Academy’s flagship location, on Saturday, June 25, as SPORTIME and John McEnroe Tennis Academy (JMTA) coaches seek to discover untapped tennis and athletic talent.
The goal of both the Tryout and the Athletic Scouting Combine is to award full or partial scholarships to SPORTIME and John McEnroe Tennis Academy programs…
